Tetracaine
2-(Dimethylamino)ethyl 4-(butylamino)benzoate
Drag to rotate. Structure from PubChem CID 5411.
Background
Listing
- Schedules
- Schedule 1 to 4, conditions apply
- Also listed as
- Amethocaine (Schedule 1, 2 and 4), see Tetracaine
- Source
- Consolidated Schedules 06 July 2026
Registered medicines
1 registered product listed
Counted through the register's ingredient index, which does not reach every record.
| Name | Brands | Dosages | Applicants | Registrations | Schedule |
|---|---|---|---|---|---|
| Amethocaine | Minims tetracaine, Covostet, Amethocaine, +3 more | 1%, cream, ointment | 4 applicants | 6 registrations | S1 to S4conditions apply |
2 more registered products name Tetracaine in their active ingredient
| Name | Brands | Dosages | Applicants | Registrations | Schedule |
|---|---|---|---|---|---|
| Amethocaine, arnica flower, chamomile flowers, copper phaeophytin, sage Cancelled | Dynexan | powder | The Premier Pharmaceutical Co Ltd | H1069 | |
| Amethocaine, neomycin, polymyxin b, tyrothricin Cancelled | Neocones | Not stated | Er Bernard Pharmaceuticals (Pty) Ltd | H1101 |
Regulatory status
Where S1 to S4 sits on the scale
Depends on which listing applies
At the least restrictive, Schedule 1: sold by a pharmacist, no doctor's prescription needed. At the most restrictive, Schedule 4: prescription-only medicine. The listings below say which applies to which form, strength or pack size.
Schedule S1 to S4, as the Consolidated Schedules list it.
Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.
Consolidated Schedules listings for Tetracaine
S4: Tetracaine
- when intended for ophthalmic or parenteral use;
- except when intended for topical use; (S1)
- except in oral preparations containing 2 percent or less of Tetracaine; (S1)
- except when contained in eye drops intended for the emergency treatment of “arc eyes”. (S2)
Consolidated Schedules 06 July 2026, lines 8152 to 8160
S2: Tetracaine
- when contained in eye drops intended for the emergency treatment of “arc eyes”
- except when intended for topical use; (S1)
- except in oral preparations containing 2 percent or less of tetracaine, per dosage unit; (S1)
- except when intended for ophthalmic or parenteral use. (S4)
Consolidated Schedules 06 July 2026, lines 2707 to 2715
S1: Tetracaine
- when intended for topical use;
- in oral preparations containing 2 percent or less of tetracaine, per dosage unit;
- except when contained in eye drops intended for the emergency treatment of “arc eyes”; (S2)
- except when intended for ophthalmic or parenteral use. (S4)
Consolidated Schedules 06 July 2026, lines 1096 to 1104
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.